Overview

Pharmacokinetics of Tedizolid Phosphate in Cystic Fibrosis

Status:
Completed
Trial end date:
2017-12-31
Target enrollment:
Participant gender:
Summary
The proposed study is designed to characterize the pharmacokinetics of intravenous and oral tedizolid in patients with Cystic Fibrosis.
Phase:
Phase 4
Details
Lead Sponsor:
University of Southern California
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Oxazolidinones
Tedizolid
Torezolid